Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm
Seunghyun Lee, Sangrye Park, Helen Lew
Korean J Ophthalmol. 2018;32(1):1-7.   Published online 2018 Jan 24     DOI: https://doi.org/10.3341/kjo.2017.0030
Citations to this article as recorded by Crossref logo
An overview of the pharmacotherapeutics for dystonia: advances over the past decade
O. Abu-hadid, J. Jimenez-Shahed
Expert Opinion on Pharmacotherapy.2022; 23(17): 1927.     CrossRef
The good toxin: 10 years of experience with botulinum toxin A in the treatment of benign essential blepharospasm
Kenneth KH Lai, Andrew KT Kuk, Edwin Chan, Simon TC Ko
European Journal of Ophthalmology.2021; 31(3): 1345.     CrossRef
Treatment of keloids and hypertrophic scars. Position statement of the Brazilian expert group GREMCIQ
G.V. Oliveira, L.D. Metsavaht, B.V Kadunc, S.K.K. Jedwab, M.S. Bressan, H.O. Stolf, R.G. Castro, S.M.F.M.C. Bezerra, D.A. Calil, F.A.Z. Addor, J.C.S. Fraga, C.M.S. Reis, E. Reis‐Filho, M.R. Silva, M. Ramos‐e‐Silva, D.M. Hexsel
Journal of the European Academy of Dermatology and Venereology.2021; 35(11): 2128.     CrossRef
Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
Bo Yin, Bin Peng, Ying Luo, Shanghua Fan, Ting Xiao, Xiaoli Zou, Hongjuan Dong
Neuropsychiatric Disease and Treatment.2021; Volume 17: 2707.     CrossRef
Treatment of blepharospasm and Meige’s syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice
Angela Jochim, Tobias Meindl, Christoph Huber, Tobias Mantel, Silke Zwirner, Florian Castrop, Bernhard Haslinger
Journal of Neurology.2020; 267(1): 267.     CrossRef
Medical treatment of blepharospasm
Dhanya Vijayakumar, Joseph Jankovic
Expert Review of Ophthalmology.2018; 13(4): 233.     CrossRef